Transcriptional Antagonism between Hmx1 and Nkx2.5 for a Shared DNA-binding Site*

Brad A. AmendtDagger §, Lillian B. SutherlandDagger , and Andrew F. Russo

From the Department of Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52242

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The recently described Hmx family of homeodomain proteins is predominately expressed in discrete regions of developing sensory tissues. In this report, we have identified the preferred DNA-binding site of the murine Hmx3 homeodomain protein by the selection and amplification binding (SAAB) technique. The consensus Hmx-binding site contained the sequence 5'-CAAGTG-3', which differs from the 5'-TAAT-3' motif commonly associated with homeodomain proteins. Instead, the Hmx consensus is similar to the 5'-CAAGTG-3'-binding sites of Nkx2.1 and Nkx2.5 homeodomain proteins. Based on mutation studies, both the 5'-CAAG-3' core and the 3'-TG dinucleotide are required for high affinity binding by Hmx3 and the homologous Hmx1 protein. A critical determinant of this specificity is the glutamine at position 50 in the third helix of the Hmx homeodomain. Hmx1 binds to the 5'-CAAGTG-3' element with an apparent dissociation constant of 20 nM. Unexpectedly, the human Hmx1 protein specifically repressed transcription from a luciferase reporter gene containing 3 copies of the 5'-CAAGTG-3' sequence. In contrast, the Nkx2.5 protein transactivated this luciferase reporter. Interestingly, co-expression of Hmx1 and Nkx2.5 attenuated each others activity, suggesting that genes containing the CAAGTG element can integrate signals from these proteins. Therefore, Hmx1 and Nkx2.5 proteins bind a unique DNA sequence and act as transcriptional antagonists.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Homeodomain genes are involved in a wide variety of developmental pathways (1-4). Mutation studies and expression patterns of several members of the homeodomain gene family have indicated a role in controlling specification of cranial structures, including development of neurons and sensory organs (2, 5-7). A novel homeodomain gene family, Hmx, was first identified by Stadler et al. (8) using low stringency screening of a human craniofacial cDNA library. Homologous Hmx genes have now been identified in a diverse number of species (9). There are three closely related members of the Hmx family in humans and mice, which are designated Hmx1, Hmx2, and Hmx3 (8, 9).1 The murine Hmx2 and Hmx3 genes were origi-nally named Nkx5.2 and Nkx5.1, respectively, based on limited homology with the Nk homeodomain family of Drosophila (10, 11). However, the Hmx family is substantially different from the Nk family (9). Alignment of the Hmx3 homeodomain protein sequence to the four Drosophila Nk genes yielded 50-61% amino acid sequence identity, which is not substantially greater than seen when Hmx3 is compared with other homeodomains, such as Drosophila Antp (47%). Furthermore, a Drosophila Hmx homologue has been identified and found to have 94% amino acid identity with the murine Hmx3 homeodomain (9). Finally, there is little or no homology between the Nkx and Hmx proteins outside the homeodomains. Hence, we have used the Hmx nomenclature for these genes, as assigned by the human gene mapping nomenclature committee (9).

The Hmx genes are believed to be important regulators of development in sensory organs and neurons based on their expression patterns in the embryo (10, 12). The expression of murine Hmx3 is especially high in the otic vesicle, neuroectodermal cells of the central nervous system, neuronal derivatives of the neural crest, including the dorsal root ganglia and myenteric ganglia, and transiently in the second branchial arch. In particular, the predominant expression in the otic vesicle and postmitotic neurons has suggested an involvement in the development of the inner ear and specification of neuronal phenotype (13). The murine Hmx genes have very similar expression patterns with two chicken homologues, GH6 and SOHo-1 gene (14, 15), suggesting that the Hmx genes play an evolutionary conserved role during development. The chicken homologue of Hmx1 (GH6) has been reported to be expressed in the developing heart (14). Nkx2.5 is expressed early during heart morphogenesis and activates early cardiac gene expression (16-19). Hmx and Nkx genes are found in overlapping regions in vertebrate embryos (10, 12, 14). In particular, Nkx2.5 and chicken Hmx1 are both expressed in the developing heart myocardium (12, 14, 16). These results suggest that Hmx and Nkx2.5 proteins both regulate early transcription events in development.

To begin to address the functional role of Hmx homeodomain proteins, we have identified the DNA-binding site of the Hmx1 and -3 proteins. We show that these Hmx proteins prefer the core binding sequence 5'-CAAG-3' and not the typical 5'-TAAT-3' core found among most homeodomain proteins (1-4). Instead, the Hmx-binding site resembles the consensus site found for Nkx2.5 protein (also called Tinman) by Chen and Schwartz (20) and Nkx2.1 protein (also called thyroid transcription factor-1) by Damante et al. (21). We demonstrate that Hmx1 represses transcription of a luciferase reporter gene containing the Hmx preferred DNA-binding site. Since Nkx2.5 transactivates this reporter and the Nkx2.5 and Hmx proteins are co-expressed in some tissues, we propose that Hmx1 and Nkx2.5 may act as transcriptional antagonists.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Expression and Purification of Hmx1 and -3 Proteins-- A fragment of the murine Hmx3 gene was PCR2 amplified from a genomic clone provided by Dr. Tom Lufkin (Mt. Sinai Medical Center). The primers were nucleotides 1232 to 1252 (5'-ggatccCCGGGCTCAGAGGACTGGAAG-3') and nucleotides 1675 to 1695 (5'-gaattcCCTGTCCCATCTCACACCGGC-3'), with BamHI and EcoRI sites (lowercase) to facilitate subcloning into pGEX4T-3 glutathione S-transferase (GST) vector (Pharmacia) and was confirmed by DNA sequencing. The resulting plasmid, pGST-Hmx3, encodes amino acids 309-458, which contains the homeodomain 20 amino-terminal flanking residues, and the entire COOH-terminal region. To make plasmid pGST-Hmx3 Gln right-arrow Lys, an antisense primer containing the point mutation (underlined), nucleotides 1423-1448, (5'-GGCGATTCTTGAACCAGATCTTGACC-3') was used with the previous 5' primer (nucleotides 1232-1252) to make a PCR megaprimer. In the second PCR step the megaprimer was used with the previous 3' primer (nucleotides 1675-1695). The PCR profile was 94 °C, 2 min; 70 °C, 2 min, 72 °C, 3.5 min for 30 cycles using Pfu DNA polymerase (Stratagene). Hmx3 Gln right-arrow Lys DNA was cloned into pGEX4T-3 and confirmed by sequencing. Plasmid pGST-Hmx1 was made by a series of sequential subcloning of the Hmx1 coding region from pBSK II Hmx1 cDNA plasmid (9) into pGEX 6P-1 (Pharmacia). The plasmids were transformed into Escherichia coli JT4000 5-IV95, a lon- protease-deficient strain, or BL21 cells. Protein was isolated as described (22), with some modifications. Cultures (500 ml) were induced with 0.1 mM isopropyl-1-thio-beta -D-galactopyranoside for 4 h at 30 °C. The bacteria were lysed in 10 ml of 10 mM Tris, pH 8.0, 150 mM NaCl, 1 mM EDTA, 2.5% low fat dry milk, 2 mg/ml aprotinin, 2 mg/ml leupeptin, 1 mg/ml pepstatin, 100 mg/ml phenylmethylsulfonyl fluoride, 5 mM dithiothreitol, 100 µg/ml lysozyme, on ice for 15 min, followed by addition of 1.5% Sarkosyl and sonication for 1 min. In later experiments, protease inhibitor mixture (Sigma) was used and 4% Triton was added prior to sonication. After removal of debris, the supernatant was incubated with 100 µl of a 1:1 (v/v) slurry of glutathione-Sepharose (Pharmacia) in phosphate-buffered saline overnight at 4 °C, then washed in phosphate-buffered saline. Hmx3 was released by cleavage with 10 units of thrombin (Sigma) at room temperature for 30 min. Hmx1 was released by cleavage with 30 units of PreScission protease (Pharmacia) for 1 h at 4 °C. All proteins were analyzed following SDS-gel electrophoresis by silver stain. In some experiments, GST-Hmx3 and GST-Hmx3 Gln right-arrow Lys were eluted using 10 mM glutathione in 50 mM Tris, pH 7.6, for 5 min at room temperature. For Western blots, the proteins were resolved by 12.5% SDS-polyacrylamide gel electrophoresis, transferred to polyvinylidene difluoride filters (Millipore), immunoblotted, and detected using ECL reagents from Amersham. The antibody directed against Hmx3 (number 19902; used at 1/1000 dilution) was raised in rabbits to a MAP-conjugated peptide in the COOH-terminal region (IVRVPILYHENSAAEGAAAA) (Research Genetics Inc., Huntsville, AL). In some experiments, immunoblots were also done using a GST antibody (used at 1/2000 dilution) (Pharmacia) (data not shown).

SAAB Assay-- SAABs were done essentially as described by Blackwell and Weintraub (23), using affinity chromatography (24). The "random" oligonucleotide contained 20 random nucleotides flanked by known sequences "b" and "a" that could be recognized by PCR primer b (5'-AGACGGATCCATTGCA-3') and PCR primer a (5'-TCCGAATTCCTACAG-3'), respectively (sequences from Ref. 23). Double-stranded random oligonucleotides were generated by annealing primer a (0.7 µg) to single-stranded random oligonucleotide (1.5 µg), then filled using Klenow polymerase, with tracer amounts of [32P]dATP to facilitate quantitation. The double-stranded oligonucleotide (500 ng) and GST-Hmx3 (500 ng) attached to glutathione-Sepharose beads were incubated in 10 volumes of binding buffer (20 mM Tris, pH 8.0, 50 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 10% glycerol) with 20 µg/ml bovine serum albumin, 2 µg/ml poly(dI-dC) at 4 °C for 1 h. The beads were concentrated and washed twice with binding buffer, then resuspended in 30 µl of H2O. A 10-µl aliquot was then PCR amplified in a 25-µl reaction for 30 cycles of 94 °C (1.5 min), 40 °C (1 min), and 72 °C (2 min). For subsequent rounds, 10 µl (approximately 50 ng) of the PCR reactions was incubated with 50 ng of protein. Products from the last round were gel purified, cloned into pGEM-T vector (Promega), and sequenced on one strand using an SP6 primer.

Electrophoretic Mobility Shift Assay (EMSA)-- Complementary oligonucleotides containing a consensus Nkx2.1 site (see Fig. 1C) (21) or a Bicoid site (5'-TAATCC-3'), with flanking partial BamHI ends were annealed and filled with Klenow polymerase to generate a 32P-labeled probe for EMSAs, as described (25). For standard binding assays, the oligonucleotide (1 pmol) was incubated in a 20-µl reaction containing binding buffer (10 mM Tris, pH 7.5, 5% glycerol, 50 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol), 0.1 µg of poly(dI-dC), 120 ng of Hmx3 (thrombin-cleaved from GST or glutathione-eluted), or 300 ng of Hmx1 (PreScission cleaved) on ice for 15 min. For competition assays, unlabeled double-stranded oligonucleotides were preincubated with the protein for 15 min on ice prior to addition of the probe. Sequences of the Nkx2.1 probe and competitor oligonucleotides, all with flanking partial BamHI ends (in lowercase), are given in the figures, with the exception of Hmx Mu3, 5'-gatccCGGACCCCCAGTGGGAGCATCTggatc-3' and Hmx Mu11, 5'-gattccTTGTTAATAATCTAATTACCCTAGggatc-3'. The samples were electrophoresed for 2 h at 250 V in an 8% polyacrylamide gel in 0.25 × TBE (22.5 mM Tris-HCl, pH 8.5, 28 mM boric acid, 0.7 mM EDTA) at 4 °C following pre-electrophoresis of the gels for 1 h at 200 V. The dried gels were visualized by exposure to autoradiographic film. For quantitative analyses to establish binding constants and relative competitions, the amount of bound and free radioactive probe was measured from dried gels using an InstantImager (Packard). The binding constants were calculated by Scatchard plots. For determination of the amount of binding competition, the ratio of bound to free probe was normalized to the absence of competitor DNA, which was set at 100%.

Expression and Reporter Constructs-- An expression plasmid containing the cytomegalovirus (CMV) promoter linked to a human Hmx1 EcoRI-BamHI fragment was constructed in pcDNA 3.1 MycHisC (Invitrogen). Dr. Yutzey, Children's Hospital Medical Center, Cincinnati, OH, kindly provided the murine Nkx 2.5 expression plasmid (pEMSV-Nkx2.5). The Hmx-TK-luc reporter plasmid has Hmx-binding sites (same oligonucleotides as used in the EMSAs (5'-gatccCACTGCCCAGTCAAGTGTTCGGATg-3' annealed to 5'-gatccATCCGAACACTTGACTGGGCAGTGg-3')) ligated into the BamHI site upstream of the thymidine kinase (TK) promoter in the TK-luc plasmid (25). Hmx-TK-luc contains three inserts, 2 in the sense and 1 in the antisense orientation. A CMV beta -galactosidase reporter plasmid (CLONTECH) was co-transfected in all experiments as a control for transfection efficiency.

Cell Culture, Transient Transfections, Luciferase, and beta -Galactosidase Assays-- COS-7 and HeLa cells were cultured and transfected as described (26) by a modification of the calcium phosphate method or electroporation. For calcium phosphate transfection, 5-10 µg of plasmid DNA was used. For electroporation, HeLa cells were mixed with 2.5 µg (or as indicated) of expression plasmids, 2.5 µg of reporter plasmid, and 0.5 µg of CMV beta -galactosidase plasmid. HeLa cells were electroporated at 220 mV and 960 microfarads (Bio-Rad) plated in 60-mm culture dishes and fed with 5% fetal calf serum and Dulbecco's modified Eagle's medium. Cells were then lysed and assayed for reporter activities and protein content by Bradford assay (Bio-Rad). Luciferase was measured using reagents from Promega. beta -Galactosidase was measured using the Galacto-Light Plus reagents (Tropix Inc.).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of the Hmx3 DNA-binding Site-- To determine the DNA-binding site of Hmx3, the SAAB technique was used with bacterial expressed GST-Hmx3 protein containing the homeodomain and COOH-terminal region. Previous studies with other homeodomain proteins have shown that the information necessary for DNA binding is contained within the homeodomain region (3, 4). For example, a truncated homeodomain-containing Nkx2.1 protein binds with the same apparent KD as the full-length protein (21). The sequences of oligonucleotides selected after 2, 3, and 5 sequential SAAB rounds are shown in Fig. 1A. As early as rounds 2 and 3, a consensus containing 5'-CAA(T/G)-3' was observed. Following the fifth round, there was a selection for oligonucleotides containing the consensus sequence 5'-CAAGTGCGTG-3'. In many cases, multiple copies of this sequence were found in the oligonucleotides. Each of the nucleotides within the consensus was highly conserved, with frequencies ranging from 75 to 100% occurrence (Fig. 1B). In particular, the 5'-CAAG-3' core was very predominant, being present in all of the selected oligonucleotides. These results indicate a strong preference for this consensus sequence.


View larger version (46K):
[in this window]
[in a new window]
 
Fig. 1.   Identification of Hmx3 binding sites. A, alignment of the PCR product sequences after 2, 3, and 5 successive SAAB rounds (number of rounds is denoted by the prefix, e.g. 2-1 is from round 2). The best match and other conserved regions are indicated in bold. The common sequences contributed from the PCR primers are indicated by a and b. B, sequence of the consensus Hmx3 DNA-binding site determined from the PCR products after 5 SAAB rounds. The frequencies of each consensus nucleotide within the best match of each oligonucleotide, and from all the sites indicated in bold are shown. C, Hmx3 protein was incubated with the Nkx2.1 consensus sequence as the radioactive probe in the absence or presence of unlabeled oligonucleotides as competitor DNAs. Competitor oligonucleotides were used at 10-, 25-, and 50-fold molar excess concentrations. The free probe and bound complex are indicated. The sequences of the DNAs are shown at the bottom of the figure with the terminal partial BamHI sites in lowercase, and the CAAGTG motif separated by vertical lines.

Comparison of Hmx3 Binding to Nkx and Hmx Consensus Sites-- Because the Hmx and Nkx2.1 and 2.5 consensus elements both contain a 5'-CAAGTG-3' motif, but the flanking sequences differed, we tested whether Hmx3 could also bind the Nkx2.1 element. Using a competitive EMSA DNA binding assay, we showed that the Hmx3 protein bound to DNA containing the Nkx2.1/2.5 consensus site and was efficiently competed by either the Nkx2.1/2.5 or the Hmx consensus motifs (Fig. 1C). Thus, Hmx3 binds both Nkx2.1/2.5 and Hmx consensus binding sites without preference for flanking sequences. As a control for binding specificity, Hmx3 binding to the 5'-CAAGTG-3' consensus sequence was not competed by an oligonucleotide containing an octamer consensus site recognized by the Oct-1 POU homeodomain. It should be noted that the 5'-CAAGTG-3' consensus site for Hmx and Nkx proteins also contains a consensus helix-loop-helix protein-binding site (5'-CANNTG-3') (27). While it was very unlikely that Hmx3 DNA binding activity was similar to helix-loop-helix proteins, we ruled out this formal possibility by demonstrating that Hmx3 did not bind to oligonucleotides containing two other 5'-CANNTG-3' motifs. Both the 5'-CAGCTG-3' and 5'-CACCTG-3' elements recognized by the AP4 and muscle creatine kinase helix-loop-helix proteins, respectively, did not bind Hmx3 (data not shown). Thus, Hmx3 specifically binds the Hmx and Nkx2.1/2.5 motifs with comparable affinities.

Mutations in the CAAG Core and Flanking TG Dinucleotide Reduce Hmx3 Binding-- The binding of Hmx3 to the CAAG core was compared with the canonical TAAT sequence found in the Antennapedia class of homeodomains (28). Hmx3 binding to the competitor was greatly reduced when the 5'-CAAG-3' sequence was mutated to a typical homeodomain-binding site that matches the Msx consensus binding site, 5'-TAATTG-3' (Msx) (Fig. 2A) (28). An even greater effect was seen when the competitor binding site was mutated at both the core and flanking dinucleotide 5'-TAATCA-3' (Mu10) (Fig. 2A). Similarly, mutation to 5'-TAATTA-3' (Hmx Mu11), which matches a consensus Idx-binding site (29), greatly reduced Hmx3 binding to the competitor (data not shown). Finally, complete removal of the CAAG core (Hmx Mu3) completely eliminated binding to the competitor (Fig. 2B). These results demonstrated that the 5'-CAAG-3' core is critical for Hmx3 binding activity.


View larger version (61K):
[in this window]
[in a new window]
 
Fig. 2.   Both the 5'-CAAG-3' core and 3'-TG dinucleotide are required for Hmx3 binding. A, Hmx3 DNA binding activity was measured by EMSA with the Nkx2.1 probe in the presence or absence of competitor DNAs at 10-, 25-, and 50-fold molar excess. The free probe and bound complexes are indicated. The oligonucleotide sequences are shown below the autoradiogram, with differences from the Hmx3 oligonucleotide underlined. The terminal partial BamHI sites are in lowercase. B, quantitation of the binding efficiency of Hmx3 from the EMSA experiments. Dried gels were quantitated using the InstantImager (Packard). The bound DNA radioactivity was measured and the inhibition of bound complex from 50-fold excess of each competitor DNA was determined. The values are normalized to 100% binding without competitor DNA, with the means and standard deviations from two to six independent shown.

The relative difference between Msx (TAATTG) and Hmx Mu10 (TAATCA) competitions indicated that the 3'-TG dinucleotide contributes to Hmx3 binding. This contribution was confirmed by the reduced Hmx3 binding to the competitor seen upon mutation of the TG in the context of the 5'-CAAG-3' core sequence (Hmx Mu2, CAAGGT) (Fig. 2A). To further test the importance of the TG dinucleotide in the absence of the 5'-CAAG-3' core, the TG was mutated to a GG (Ftz) or AT (Hmx Mu9) following a 5'-TAAT-3' core. Hmx3 did not bind either of these DNAs in competition assays (Fig. 2A). Quantitation of the effect of each competitor on Hmx3 binding is shown in Fig. 2B.

We also confirmed that sequences outside the 5'-CAAG-3' and flanking TG dinucleotide motif are not required for Hmx3 binding. This was important to test since the SAAB consensus had contained an additional four nucleotides (CGTG) downstream of the CAAGTG motif. Changes in these nucleotides (Hmx Mu4) did not noticeably affect Hmx3 binding activity within the parameters of the competition assay (10-50-fold molar excess) (Fig. 2A). This is consistent with Hmx3 binding to the Nkx2.1/2.5 consensus sequence, which also lacks the 3'-CGTG (Fig. 1C). Taken together these results show that both the 5'-CAAG-3' and the 3'-TG dinucleotide are the key components of the DNA-binding site.

Mutation in the Recognition Helix of Hmx3 Reduces DNA Binding Activity-- It has been shown that the 3'-dinucleotide of the DNA-binding site can confer binding specificity that is determined by the amino acid at position 50 of the classical TAAT binding homeodomain proteins (4, 30). In addition, Damante et al. (21) demonstrated that the glutamine at position 50 is important for recognition of the TG dinucleotide in the Nkx2.1 consensus DNA-binding site, 5'-CAAGTG-3'. Hmx3 also contains this glutamine in the highly conserved third helix, suggesting that this residue may play a similar role in Hmx3. We made the corresponding mutation in Hmx3 changing the glutamine (Q) to a lysine (K). The glutamine to lysine mutation decreased binding to undetectable levels (Fig. 3A). As a control, the mutant protein could bind to a bicoid element (5'-TAATCC-3') (Fig. 3B). The lysine at position 50 is important for recognition of the CC dinucleotide in the bicoid element (4, 31). GST-Hmx3 Gln right-arrow Lys mutant protein binding to the bicoid probe was competed by the bicoid competitor DNA but not by Hmx DNA. For comparison, the wild type Hmx3 protein bound very poorly to the bicoid probe and was effectively competed by the Hmx element (Fig. 3B). Expression of the GST-Hmx3 Gln right-arrow Lys protein in bacteria was confirmed by Western blots with an antibody raised against a COOH-terminal peptide conserved in the Hmx family (Fig. 3C). Varying concentrations of both GST-Hmx3 and GST-Hmx3 Gln right-arrow Lys proteins were analyzed for binding to the 5'-CAAGTG-3' sequence. Thus, Hmx3 binding to the 5'-CAAGTG-3' motif requires the glutamine at position 50 of the homeodomain.


View larger version (88K):
[in this window]
[in a new window]
 
Fig. 3.   The glutamine at position 50 in the homeodomain is required for Hmx3 binding to the 5'-CAAGTG-3' sequence. A, GST-Hmx3 and GST-Hmx3 Gln right-arrow Lys DNA binding activity was measured by EMSA with the Nkx2.1 probe. Several concentrations of each protein were used for binding: 0.1, 0.5, 1 µl of GST-Hmx3, and 1, 5, 10 µl of GST-Hmx3 Gln right-arrow Lys. The free probe and bound complexes are indicated. B, GST-Hmx3 Gln right-arrow Lys DNA binding activity was measured by EMSA with the bicoid probe (5'-TAATCC-3'). Approximately 120 ng (0.1 µl) of GST-Hmx3 and GST-Hmx3 Gln right-arrow Lys (1.0 µl) proteins were used to determine binding activity. Binding activity was measured in the presence and absence of competitor DNA at 50-fold molar excess (Bic, bicoid competitor). C, Western blot of bacterial expressed GST-Hmx3 and GST-Hmx3 Gln right-arrow Lys proteins. Equal volumes of GST affinity purified fusion proteins (4 µl) were resolved on a 12.5% SDS-polyacrylamide gel, transferred to a polyvinylidene difluoride filter, and immunoblotted using an antibody against a COOH-terminal peptide of Hmx3.

Hmx1 Binds the 5'-CAAGTG-3' Element with a Similar Specificity as Hmx3-- To determine if the binding characteristics of the homologous human Hmx1 protein were similar to Hmx3 we used a competitive EMSA DNA binding assay as described above. Hmx1 was chosen so as to extend our findings to another member of the Hmx family. Human Hmx1 has 92% amino acid identity to murine Hmx3 in the homeodomain. We demonstrate that the Hmx1 protein bound to DNA containing the Nkx2.1/2.5 site and was efficiently competed by the Nkx and Hmx consensus elements, but not other motifs (Fig. 4A). Hmx1 had the same DNA binding specificity as shown for the truncated Hmx3 protein (Fig. 4B).


View larger version (36K):
[in this window]
[in a new window]
 
Fig. 4.   Hmx1 and Hmx3 have similar DNA binding specificities. A, Hmx1 DNA binding activity was measured by EMSA with the Nkx2.1 probe in the presence or absence of competitor DNA at 50-fold molar excess. The free probe and bound complex detected in the autoradiograms are indicated. B, quantitation of the binding efficiency of Hmx1 from the EMSA experiments. Binding was measured as described in the legend to Fig. 2. The means and standard deviations from two to six independent experiments are shown. C, Scatchard plot of Hmx1 protein binding to increasing amounts of Nkx2.1 probe. D, Scatchard plot of GST-Hmx3 protein binding to increasing amounts of bicoid probe. The free and bound forms of DNA were quantitated using the InstantImager.

The binding affinity of Hmx1 to the 5'-CAAGTG-3' sequence was measured by EMSA (Fig. 4C). The apparent dissociation constant (KD) was calculated using different protein and probe concentrations by Scatchard analysis as 20 nM (Fig. 4C). This KD is higher than those reported for Nkx2.1 (3 nM), Antennapedia (1.2 nM), and Engrailed (1-2 nM) (4, 20, 21). The KD using the GST-Hmx3 fusion protein was 1.4 nM, which is very similar to the reported KD values of other homeodomain proteins (Fig. 4D). We have seen that the GST moiety can affect binding of the Pitx2 homeodomain protein. GST-Pitx2 has an apparent KD of ~0.5 nM while the non-fusion purified Pitx2 protein demonstrated a KD of 50 nM (26).

Hmx1 Specifically Represses Transcription from a Promoter Containing the 5'-CAAGTG-3' sequence-- To determine if Hmx1 could regulate a reporter gene containing the 5'-CAAGTG-3' sequence we co-transfected an expression vector encoding human Hmx1 (CMV-Hmx1) with a luciferase reporter containing three Hmx-binding sites (Hmx-TK-luc) into HeLa cells. As a control for transfection efficiency, a CMV beta -galactosidase reporter was also included. Unexpectedly, Hmx1 repressed transcription from the Hmx-TK-luc reporter approximately 4-fold compared with control cells transfected with the CMV vector without Hmx1 (Fig. 5A). In the absence of the Hmx sites, there was only marginal repression of the reporter by Hmx1 (Fig. 5A). Thus, Hmx1 specifically represses promoter activity of a reporter containing the 5'-CAAGTG-3' sequence.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5.   Transcriptional repression of a 5'-CAAGTG-3' containing luciferase reporter by Hmx1. A, HeLa cells were transfected with either Hmx-TK-luciferase reporter gene containing three copies of the Hmx binding sequence (striped boxes) or the parental TK-luciferase reporter without the Hmx sites. The cells were co-transfected with either the CMV-Hmx1 expression plasmid (+) or the CMV plasmid without Hmx1 (-). To control for transfection efficiency, all transfections included the CMV beta -galactosidase reporter. Cells were incubated for 24 h, then assayed for luciferase and beta -galactosidase activities. The activities are shown relative to the TK-luc without Hmx1 control (mean ± S.E. (n = 8) from four independent experiments). All luciferase activities were normalized to beta -galactosidase activity. The mean TK-luciferase activity without Hmx1 expression was about 1600 light units per 20 µg of protein, and the beta -galactosidase activity was about 15,000 light units per 20 µg of protein. B, HeLa cells were transfected with either Hmx-TK-luciferase reporter gene containing three copies of the Hmx binding sequence (striped boxes) or the parental TK-luciferase reporter without the Hmx sites. The cells were co-transfected with either the Nkx2.5 expression plasmid (+) or a CMV plasmid without Nkx2.5 (-). Activities were normalized as described in panel A, from three independent experiments (n = 6).

For comparison, we asked if Nkx2.5 could transactivate the 5'-CAAGTG-3' reporter under our conditions. We found that Nkx2.5 caused a 3-fold stimulation of this reporter and had no effect on the reporter without the 5'-CAAGTG-3' elements (Fig. 5B). This is consistent with published reports that Nkx2.1 and Nkx2.5 are transcriptional activators (20, 21). Thus, Hmx1 represses, while Nkx2.5 activates, transcription via the 5'-CAAGTG-3' element.

Hmx1 and Nkx2.5 Act as Transcriptional Antagonists-- Since Nkx2.5 (Tinman) and Hmx1 are expressed in the developing heart and both bind the same core DNA element (5'-CAAGTG-3') we then asked if these factors had an antagonistic effect on transcription. The Nkx2.5 and Hmx1 expression vectors were co-transfected along with the 5'-CAAGTG-3' TK-luc reporter plasmid. Co-transfection of equal amounts of each vector resulted in an overall 2-fold repression of transcription (Fig. 6). This is an intermediate value between the 3-fold activation by Nkx2.5 alone and the 4-fold repression by Hmx1 alone. These results indicate that Hmx1 can antagonize Nkx2.5 activation of the reporter plasmid, and conversely Nkx2.5 can attenuate Hmx1 repression. To vary the relative amounts of Hmx1 protein compared with Nkx2.5 in the transient transfection assay, we varied the amount of expression vector DNA. Antagonism was observed even with lower levels of Hmx1 expression vector DNA (Fig. 6). These results suggest that the relative levels of Nkx2.5 and Hmx1 proteins may regulate the activity of genes containing the CAAGTG element.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Transcriptional antagonism of the 5'-CAAGTG-3'-containing luciferase reporter by Nkx2.5 and Hmx1. HeLa cells were co-transfected with the Hmx-TK-luciferase reporter gene and either the Nkx2.5 expression plasmid (7.5 µg), the CMV-Hmx1 expression plasmid (0-7.5 µg). The total amount of DNA was held constant by addition of the empty CMV vector (-). To control for transfection efficiency, all transfections were normalized to beta -galactosidase from a co-transfected CMV beta -galactosidase reporter. Cells were incubated for 24 h, then assayed for luciferase and beta -galactosidase activities. The activities are shown relative to Hmx-TK-luc without Hmx1 or Nkx2.5 expression (mean ± S.E. (n = 6) from three independent experiments).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

This study represents the first molecular/biochemical characterization of members of the Hmx homeodomain family. Hmx 1 and Hmx 3 strongly prefer the 5'-CAAGTG-3' DNA-binding site in contrast to the 5'-TAAT-3' motif preferred by nearly all other metazoan homeodomain proteins. The usual bias among homeodomain proteins for a 5'-TAAT-3' core was recently confirmed by Wilson et al. (30) using the SAAB selection strategy similar to the one used in this study. For Hmx proteins, both the 5'-CAAG-3' core and the 3'-flanking TG dinucleotide contribute to binding specificity. This binding site has a striking similarity to the consensus sites identified for the Nkx2.5 and Nkx2.1 proteins. Chen and Schwartz (20) used a similar SAAB methodology with Nkx2.5 to identify a high affinity 5'-TNNAGTG-3' motif and lower affinity 5'-TAAT-3' containing motifs. Similarly, Damante et al. (21) have shown that Nkx2.1 bound the core consensus sequence 5'-CAAGTG-3', which is also recognized by the Nkx2.5 protein (20). Thus, Hmx binds to the same 5'-CAAGTG-3' sequence as Nkx2.1 and 2.5 proteins.

DNA binding specificity of homeodomains is dictated mostly by residues in the recognition helix and the NH2-terminal arm (21, 30, 32-34). We have shown that the glutamine at position 50 of the Hmx recognition helix is essential for binding. The position 50 residue has been shown to be critical for recognizing the 3'-dinucleotide of the DNA binding sequence of both TAAT-binding and CAAG-binding proteins (4, 21, 30). For example, conversion of a glutamine to lysine at position 50 in the Ftz homeodomain changed the recognition sequence from 5'-TAATGG-3' to 5'-TAATCC-3' (32-34). The latter sequence is bound by the Bicoid protein, which contains a lysine at position 50. Consequently, Hmx requires the same residue that has also been identified as a critical determinant in other groups of homeodomain proteins. Recently, a detailed set of experiments was performed to determine the amino acids required for binding to the 5'-CAAGTG-3' sequence by Nkx2.1 (35). This study demonstrated that the amino acid in position 54 of the homeodomain is involved in the recognition of the guanosine at the 3' end of the core sequence 5'-CAAG-3'. The authors further demonstrated that the 5' cytosine is recognized by the amino acids located in positions 6, 7, and 8 of the NH2-terminal arm. Comparison of the Nkx and Hmx sequences supports and extends the conclusions that these residues contribute to binding to the 5'-CAAGTG-3' sequence. Specifically, Nkx2.1 has a tyrosine at position 54 that is conserved among Nkx2 family members. In contrast, all the Hmx family members contain an asparagine at this position. These residues are similar in that both have bulky polar side chains. The Nkx2.1 residues at positions 6, 7, and 8 are valine, leucine, phenylalanine, while Hmx proteins contain threonine, valine (isoleucine in one case), phenylalanine at these positions. Between the two families, positions 7 and 8 are identical or homologous, while the residues at position 6 are structurally quite different. Hence the difference in position 6, together with the different, albeit similar, residues at position 54, suggests that there is some flexibility in the binding determinants of the CAAG-binding group of homeodomain proteins.

We have demonstrated that Hmx1 can specifically repress transcription of a reporter gene containing 3 copies of the 5'-CAAGTG-3' sequence. Furthermore, we have shown that Hmx1 and Nkx2.5 act as transcriptional antagonists. The degree of Nkx2.5 transactivation that we observed was similar to previous results with the Nkx2.5 protein on multimers of its binding site (20). Since both Nkx2.5 and chicken Hmx1 (GH6) have overlapping expression patterns during heart development (12, 14), these proteins may also differentially regulate genes containing the 5'-CAAGTG-3' element. There is precedence for the regulation of transcription during differentiation by transcriptional antagonists. A well studied example is the transcriptional antagonism between the homeodomain proteins Ftz and Engrailed, where Engrailed represses or quenches the activation of Ftz (36, 37). Recently, it has also been shown that the winged helix HNF-3alpha and HNF-3beta proteins have antagonistic transcriptional regulatory functions (38). HNF-3beta activates transcription and HNF-3alpha represses activity by competing for HNF-3beta binding to a shared DNA element.

In addition to our experimental system, there are now at least three reports of 5'-CAAGTG-3' type elements controlling gene transcription in response to Nkx2.1 and Nkx2.5. A 5'-CAAGTG-3' response element for Nkx2.1 has been identified in the rat thyroglobulin promoter near the TATA box (21). Recently, targets for Nkx2.5 have been identified in the atrial natriuretic factor promoter (39) and the cardiac alpha -actin gene (40). The observation that natural Nkx-target genes can be regulated by 5'-CAAGTG-3' elements strengthens the likelihood that Hmx proteins will also regulate genes containing this element. Furthermore, the shared DNA binding specificity and overlapping expression patterns suggests that the Hmx and Nkx gene families may recognize and coordinately regulate overlapping sets of target genes during specification of cardiac and neuronal phenotypes.

    ACKNOWLEDGEMENTS

We thank Drs. Scott Stadler, Tom Lufkin, and Jeffrey Murray for helpful discussions and kindly providing Hmx clones. We thank Dr. Katherine Yutzey for generously providing the Nkx2.5 expression vector.

    FOOTNOTES

* This work was supported by National Institutes of Health Grants HD25969 and DE09170 (to A. F. R.), with tissue culture support from DK25295, and National Institutes of Health Postdoctoral Training Fellowship DK07018 (to B. A. A.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Contributed equally to the results of this report.

§ To whom correspondence should be addressed: Dept. of Physiology and Biophysics, University of Iowa, Iowa City, IA 52242. Tel.: 319-335-7873; Fax: 319-335-7330; E-mail: brad-amendt{at}uiowa.edu.

1 J. Murray, personal communication.

    ABBREVIATIONS

The abbreviations used are: PCR, polymerase chain reaction; SAAB, selection and amplification binding; EMSA, electrophoretic mobility shift assay; GST, glutathione S-transferase; CMV, cytomegalovirus; luc, luciferase; HNF, hepatocyte nuclear factor.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Scott, M. P., Tamkun, J. W., and Hartzel, G. W. (1989) Biochim. Biophys. Acta 989, 25-48[CrossRef][Medline] [Order article via Infotrieve]
  2. McGinnis, W., and Krumlauf, R. (1992) Cell 68, 283-302[Medline] [Order article via Infotrieve]
  3. Kornberg, T. B. (1993) J. Biol. Chem. 268, 26813-26816[Free Full Text]
  4. Gehring, W. J., Qian, Y. Q., Billeter, M., Furukubo-Tokunaga, K., Schier, A. F., Resendez-Perez, D., Affolter, M., Otting, G., and Wuthrich, K. (1994) Cell 78, 211-223[Medline] [Order article via Infotrieve]
  5. Gruss, P., and Walther, C. (1992) Cell 69, 719-722[Medline] [Order article via Infotrieve]
  6. He, X., Treacy, M. N., Simmons, D. M., Ingraham, H. A., Swanson, L. W., and Rosenfeld, M. G. (1989) Nature 340, 35-42[CrossRef][Medline] [Order article via Infotrieve]
  7. Herr, W., and Cleary, M. A. (1995) Genes Dev. 9, 1679-1693[CrossRef][Medline] [Order article via Infotrieve]
  8. Stadler, H. S., Padanilam, B. J., Beutow, K., Murray, J. C., and Solursh, M. (1992) Proc. Natl. Acad. Sci. U. S. A. 89, 11579-11583[Abstract]
  9. Stadler, H. S., Murray, J. C., Leysens, N. J., Goodfellow, P. J., and Solursh, M. (1995) Mamm. Genome 6, 383-388[Medline] [Order article via Infotrieve]
  10. Bober, E., Baum, C., Braun, T., and Arnold, H. (1994) Dev. Biol. 162, 288-303[CrossRef][Medline] [Order article via Infotrieve]
  11. Kim, Y., and Nirenberg, M. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7716-7720[Abstract]
  12. Rinkwitz-Brandt, S. R., Justus, M., Oldenettel, I., Arnold, H. H., and Bober, E. (1995) Mech. Dev. 52, 371-381[CrossRef][Medline] [Order article via Infotrieve]
  13. Hadrys, T., Braun, T., Rinkwitz-Brandt, S., Arnold, H., and Bober, E. (1998) Development 125, 33-39[Abstract/Free Full Text]
  14. Stadler, H. S., and Solursh, M. (1994) Dev. Biol. 161, 251-262[CrossRef][Medline] [Order article via Infotrieve]
  15. Deitcher, D. L., Fekete, D. M., and Cepko, C. L. (1994) J. Neurosci. 14, 486-498[Abstract]
  16. Lints, T. J., Parsons, L. M., Hartley, L., Lyons, I., and Harvey, R. P. (1993) Development 119, 419-431[Abstract/Free Full Text]
  17. Durocher, D., Charron, F., Warren, R., Schwartz, R. J., and Nemer, M. (1997) EMBO J. 16, 5687-5696[Abstract/Free Full Text]
  18. Sepulveda, J. L., Belaguli, N., Nigam, V., Chen, C., Nemer, M., and Schwartz, R. J. (1998) Mol. Cell. Biol. 18, 3405-3415[Abstract/Free Full Text]
  19. Lee, Y., Shioi, T., Kasahara, H., Jobe, S. M., Wiese, R. J., Markham, B. E., and Izumo, S. (1998) Mol. Cell. Biol. 18, 3120-3129[Abstract/Free Full Text]
  20. Chen, C., and Schwartz, R. J. (1995) J. Biol. Chem. 270, 15628-15633[Abstract/Free Full Text]
  21. Damante, G., Fabbro, D., Pellizzari, L., Civitareale, D., Guazzi, S., Schwartz, M., Cauci, S., Quadrifoglio, F., Formisano, S., and Di Lauro, R. (1994) Nucleic Acids Res. 22, 3075-3083[Abstract]
  22. Frangioni, J. V., and Neel, B. G. (1993) Anal. Biochem. 210, 179-187[CrossRef][Medline] [Order article via Infotrieve]
  23. Blackwell, T. K., and Weintraub, H. (1990) Science 250, 1104-1110[Medline] [Order article via Infotrieve]
  24. Wilson, D., Sheng, G., Lecuit, T., Dostani, N., and Desplan, C. (1993) Genes Dev. 7, 2120-2134[Abstract]
  25. Tverberg, L. A., and Russo, A. F. (1993) J. Biol. Chem. 268, 15965-15973[Abstract/Free Full Text]
  26. Amendt, B. A., Sutherland, L. B., Semina, E., and Russo, A. F. (1998) J. Biol. Chem. 273, 20066-20072[Abstract/Free Full Text]
  27. Davis, R. L., Cheng, P-F., Lassar, A. B., and Weintraub, H. (1990) Cell 60, 733-746[Medline] [Order article via Infotrieve]
  28. Hayashi, S., and Scott, M. P. (1990) Cell 63, 883-894[Medline] [Order article via Infotrieve]
  29. Miller, C. P., McGehee, R. E., and Habener, J. F. (1994) EMBO J. 13, 1145-1156[Abstract]
  30. Wilson, D. S., Sheng, G., Jun, S., and Desplan, C. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 6886-6891[Abstract/Free Full Text]
  31. Driever, W., and Nusslein-Volhard, C. (1989) Nature 337, 138-143[CrossRef][Medline] [Order article via Infotrieve]
  32. Percival-Smith, A., Muller, M., Affolter, M., and Gehring, W. J. (1990) EMBO J. 9, 3967-3974[Abstract]
  33. Hanes, S. D., and Brent, R. (1989) Cell 57, 1275-1283[Medline] [Order article via Infotrieve]
  34. Treisman, J., Gonczy, P., Vashishtha, M., Harris, E., and Desplan, C. (1989) Cell 59, 553-562[Medline] [Order article via Infotrieve]
  35. Damante, G., Pellizzari, L., Esposito, G., Fogolari, F., Viglino, P., Fabbro, D., Tell, G., Formisano, S., and Di Lauro, R. (1996) EMBO J. 15, 4992-5000[Abstract]
  36. Jaynes, J. B., and O'Farrell, P. H. (1988) Nature 336, 744-749[CrossRef][Medline] [Order article via Infotrieve]
  37. Han, K., Levine, M. S., and Manley, J. L. (1989) Cell 56, 573-583[Medline] [Order article via Infotrieve]
  38. Duncan, S. A., Navas, M. A., Dufort, D., Rossant, J., and Stoffel, M. (1998) Science 281, 692-695[Abstract/Free Full Text]
  39. Durocher, D., Chen, C., Ardati, A., Schwartz, R. J., and Nemer, M. (1996) Mol. Cell. Biol. 16, 4648-4655[Abstract]
  40. Chen, Y., Bei, M., Woo, I., Satokata, I., and Maas, R. (1996) Dev. 122, 3035-3044[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.